Curis (CRIS) Gross Profit Growth (1y) (2013 - 2025)
Curis (CRIS) Gross Profit Growth (1y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Curis |
8.27 Mn |
-6.73 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-65.81% |
| Sep 30, 2025 |
8.66% |
| Jun 30, 2025 |
7.85% |
| Mar 31, 2025 |
16.04% |
| Dec 31, 2024 |
25.97% |
| Sep 30, 2024 |
4.90% |
| Jun 30, 2024 |
19.36% |
| Mar 31, 2024 |
-10.29% |
| Dec 31, 2023 |
-6.18% |
| Sep 30, 2023 |
0.36% |
| Jun 30, 2023 |
-9.70% |
| Mar 31, 2023 |
15.09% |
| Dec 31, 2022 |
-6.48% |
| Sep 30, 2022 |
-4.33% |
| Jun 30, 2022 |
8.34% |
| Mar 31, 2022 |
-5.05% |
| Dec 31, 2021 |
4.84% |
| Sep 30, 2021 |
10.78% |
| Jun 30, 2021 |
-3.04% |
| Mar 31, 2021 |
-19.50% |
